FIFNX
Price
$24.00
Change
-$0.71 (-2.87%)
Updated
Feb 21 closing price
Net Assets
199.32M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

FIFNX vs GFACX

Header iconFIFNX vs GFACX Comparison
Open Charts FIFNX vs GFACXBanner chart's image
Fidelity Advisor Founders
Price$24.00
Change-$0.71 (-2.87%)
VolumeN/A
Net Assets199.32M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
FIFNX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIFNX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIFNX is a Hold and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. FIFNX (199M). FIFNX pays higher dividends than GFACX: FIFNX (0.09) vs GFACX (0.00). FIFNX was incepted earlier than GFACX: FIFNX (6 years) vs GFACX (24 years). FIFNX is a more actively managed with annual turnover of: 51.00 vs. GFACX (31.00). FIFNX has a lower initial minimum investment than GFACX: FIFNX (0) vs GFACX (250). FIFNX annual gain was more profitable for investors over the last year : 18.69 vs. GFACX (10.15). FIFNX return over 5 years is better than : 92.56 vs. GFACX (32.83).
FIFNXGFACXFIFNX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD2.6522.98089%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets199M304B0%
Annual Yield % from dividends0.090.00-
Returns for 1 year18.6910.15184%
Returns for 3 years44.7417.69253%
Returns for 5 years92.5632.83282%
Returns for 10 yearsN/A55.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding